References
- Centers for Disease Control and Prevention. (2017). HIV Care Continuum. Retrieved from https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493–450. doi: 10.1056/NEJMoa1105243
- Doctors Without Borders. (2016). MSF Report shows price of newer HIV medicines 18 times more expensive than first-line treatment. http://www.doctorswithoutborders.org/article/msf-report-shows-price-newer-hiv-medicines-18-times-more-expensive-first-line treatment
- Gourlay, A., Noori, T., Pharris, A., Axelsson, M., Costagliola, D., Cowan, S., … Porter, K. (2017). The human immunodeficiency virus continuum of care in European Union countries in 2013: Data and challenges. Clinical Infectious Diseases, 64(12), 1644–1656. doi: 10.1093/cid/cix212
- Haberer, J. E., Sabin, L., Amico, K. R., Orrel, C. l., Galárraga, O., Tsai, A. C., … Bangsberg, D. R. (2017). Improving antiretroviral therapy adherence in resource-limited settings at scale: A discussion of interventions and recommendations. Journal of the International AIDS Society, 20, 21371. doi: 10.7448/IAS.20.1.21371
- Hall, H. I., Gray, K. M., Tang, T., Li, J., Shouse, R. L., & Mermin, J. (2012). Retention in care of adults and adolescents living with HIV in 13 U.S. Areas. Journal of Acquired Immune Deficiency Syndrome, 60(1), 77–82. doi: 10.1097/QAI.0b013e318249fe90
- The Henry Kaiser Family foundation. (2017). AIDS Drugs Assistance Program (ADAPs). https://www.kff.org/hivaids/fact-sheet/aids-drug-assistance-programs/
- The INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373, 795–807. doi: 10.1056/NEJMoa1506816
- U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. (2017a). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, Table 16. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0
- U. S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. (2017b). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, Table 9. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0
- Wilson, I. B., Bangsberg, D. R., Shen, J., Simoni, J. M., Reynolds, N. R., Goggin, K., … Liu, H. (2013). Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: Results from the multisite adherence collaboration on HIV 14 study. Journal of Acquired Immune Deficiency Syndrome, 64(5), 448–454. doi: 10.1097/QAI.0000000000000025